Concepedia

Mei‐Juan Tu

MT

36

Publications

1.3K

Citations

24

H-Index

2011

Active since

Affiliations

University of California, Davis(Current)

Zhejiang University

Roswell Park Comprehensive Cancer Center

Wuhan University

Zhongnan Hospital of Wuhan University

Mei‐Juan Tu is an author at University of California, Davis specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

2011–2023

36

Publications

36

Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression

Xin Li, Ye Tian, Mei‐Juan Tu et al. · Acta Pharmaceutica Sinica B · 2018 · 68 citations · Full text

Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics

Wanrong Yi, Mei‐Juan Tu, Zhenzhen Liu et al. · Acta Pharmaceutica Sinica B · 2019 · 66 citations · Full text

A reliable LC-MS/MS method for the quantification of natural amino acids in mouse plasma: Method validation and application to a study on amino acid dynamics during hepatocellular carcinoma progression

Zhenzhen Liu, Mei‐Juan Tu, Chao Zhang et al. · Journal of Chromatography B · 2019 · 64 citations · Full text

, , +12

Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy

Pui Yan Ho, Zhijian Duan, Neelu Batra et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 63 citations · Full text

Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth

Yong Zhao, Mei‐Juan Tu, Yi-Feng Yu et al. · Biochemical Pharmacology · 2015 · 62 citations · Full text

, , +12

Rows per page

1–5 of 36